Below you will find a list of potential funding opportunities for those looking to undertake COVID-19 research. This list will be updated with further information regularly.

Funding opportunities and guidance are evolving as the COVID-19 pandemic continues. If you can offer funding for research during the pandemic, or are aware of other organisations offering research funding that are not featured below, please get in touch and let us know.

COVID-19 Funding Dashboards

The following organisations are maintaining lists of funding opportunities for COVID-19 research:

  • GloPID-R Resources
    List of downloadable learning resources, funding opportunities, webinars and publications, all of which have been developed by GloPID-R members
  • Frontiers Cornonavirus Funding Monitor
    A curated list of open funding calls and other support for researchers, non-profit organizations and commercial organizations, specifically for COVID-19 and coronavirus-related research. Updated daily.
  • UKCDR - Funding Calls Dashboard
    The UK Collaborative on Development Research has developed a dashboard for the latest COVID-19 R&D funding opportunities. These range from major initiatives to small research grants, workshop and travel grants, prizes and awards, and individual fellowships and studentships. The dashboard collates funding opportunities for international development research based in the UK, but calls look to support international projects and work in LMICs.

Specific COVID-19 Funding Sources


Areas of Interest 

Further Information

National Science Foundation

The NSF is considering proposals for cooperative projects involving U.S. and foreign organizations.

  • To conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19.

  • To inform and educate about the science of virus transmission and prevention.

  • To encourage the development of processes and actions to address this global challenge.

Requests for the Rapid Response Research (RAPID) funding mechanism may be for up to $200K and up to one year in duration. Well-justified proposals that exceed these limits may be entertained. All questions should be directed either to a program officer managing an NSF program with which the research would be aligned or to:

Biomedical Advanced Research and Development Authority

BARDA is investing in an array of medical countermeasures to diagnose, treat, or protect against the 2019 novel coronavirus under the BARDA Broad Agency Announcement.

  • Diagnostic assays for human pan-coronaviruses

  • Point-of-Care diagnostic assays for SARS-CoV-2 virus

  • Diagnostic assay to detect COVID-19 disease

  • Nonclinical model

  • Vaccines for novel coronavirus

  • Therapeutics for novel coronavirus

  • Ventilators

  • Immunomodulators or therapeutics targeting lung repair

  • Pre-exposure and post-exposure prophylaxis for novel coronavirus exposure

  • Respiratory protective devices

  • Advanced Manufacturing Technologies

'If you are interested in partnering on a COVID-19 medical countermeasure, submit your ideas to a platform that reaches a host of potential federal partners! Submit a brief description and supporting materials through our CoronaWatch Portal.'

The African Academy of Sciences

The African Academy of Sciences (AAS) is keen to play a central role in building African Research and Development (R&D) capacity to fight COVID-19 by managing day-to-day running of the proposed fund for COVID-19 R&D priorities in Africa.

This rolling call supported by Sida (Sweden), Wellcome Trust, and Bill and Melinda Gates Foundation is a call to action for African scientists to attend to the research and development needs of the COVID-19 outbreak for the continent that have been identified.



  • Epidemiological studies

  • Clinical management

  • Infection prevention and control, including health care protection

  • Candidate vaccines, diagnostics and therapeutics

  • Ethical considerations for research

  • Social sciences in a pandemic response

Call budget: US$ 200 000 maximum for a single grant

Call opens: May 07, 2020

Application deadline: June 30, 2020

Patient-Centered Outcomes Research Institute

This call aims to support patient-engaged and patient-centred comparative clinical effectiveness research on COVID-19. The aims are to strengthen the understanding of different approaches to mitigate the impact of COVID-19 on individuals, communities, healthcare providers and healthcare systems and to provide evidence to inform clinical and public health responses, decision making and planning. 

  • Adaptations to healthcare delivery
  • Impact of COVID-19 on vulnerable populations;
  • Impact of COVID-19 on healthcare workforce well-being, management and training

The total budget is USD 30 million. Grants for small studies are worth up to USD 2.5m each and grants for large studies are worth up to USD 5m each. The maximum project period is two years.

Closing date: 26th May 2020
Applications due by 5pm ET

Country of applicant institution: Any

British Academy

The British Academy, with support from the Department for Business, Energy and Industrial Strategy, invites applications for its special research grants on COVID-19. These enable humanities and social science researchers to bring their scientific insights to bear on the global health pandemic resulting from COVID-19. 

  • Ethical and behavioural issues raised by the pandemic
  • Implications of migration on disease transmission
  • Feasibility and effectiveness of policy responses aimed at preventing or containing COVID-19, including secondary impacts such as school closures and quarantine
  • Past experience of epidemics, pandemics and quarantine
  • Communication of risk to the wider public
  • Behavioural studies understanding how people have been affected, both mentally and physically by living through the pandemic
  • Community responses to crisis
  • Access and equity to essential services, including digital communications and technologies
  • Translation and analysis of information for multilingual populations
  • Role of arts and culture in community building, recovery and resilience
  • Strategies to combat misinformation
  • Impacts on socio-economically disadvantaged groups.

Grants are worth up to £10,000 each and can last for up to two years. Funding supports direct costs of research.

Closing date: 27th May 2020
Applications due by 5pm UK time

Country of applicant institution: United Kingdom

Medical Research Council and other funders

The Medical Research Council, the Department for International Development, the Economic and Social Research Council and Wellcome invite applications for their foundation grants, under their seventh health systems research initiative call. This supports research that addresses key questions on strengthening and improving health systems in LMICs.

The aim is to fund methodologically rigourous, high-quality interdisciplinary research that:

  • Generates evidence on the structure and dynamics of health systems in general and on how to improve health systems for people living in LMICs through the delivery of evidence-based interventions or structural changes
  • Provides evidence that is of direct relevance to decision-makers and practitioners in the field, linking health systems with defined outcomes
  • Demonstrates an appreciation of current theories and frameworks in health systems research
  • Demonstrates how interventions relate to and affect wider elements of the system such as governance, financing, health workforce, information systems, service delivery, where focussed on a particular aspect of the health system

Researchers based at research organisations in the UK or LMICs may apply. Projects with a LMIC PI are strongly encouraged and all proposals must include co-investigators from the LMIC in which the research is to take place.

Grants are worth up to £200,000 each for up to two years.

Closing date: 28th May 2020
Applications are invited between 27 February and 4pm, 28 May 2020.

Country of applicant institution: See website for list of countries

World Health Organization

The WHO invites tenders for its call to provide evidence synthesis on child health acute respiratory infections and a pneumonia guideline update. The tenderer will produce three linked reviews and synthesis of the current knowledge on ARI, especially pneumonia case management and prevention in children, in order to update and expand the current technical normative guidance on ARI.


The three evidence syntheses should focus on the following issues:

  • Review one – the current pneumonia disease burden and related trends, status of guidance, new research that could affect technical guidance, status of programmes, status in humanitarian contexts, and projected impact of the COVID-19 pandemic
  • Review two – what we know about disease etiologies, vaccine efficacy, and emerging anti-microbial resistance data
  •  Review three – description of the burden, diagnostic criteria, treatment options, experiences and further research recommendations for ARI and pneumonia prevention and treatment in children aged 5 to 9 years

Not-for-profit institutions operating in the field of research synthesis, with proven experience in child health, may submit bids. Previous work with WHO, other international organisations or major institutions in the field is desirable, experience in conducting systematic reviews of scientific literature is required.The contract term will run from 15 June to 30 September 2020.

Closing date: 31st May 2020
Tenders due by 8am Geneva time. 
This is a one-off opportunity. We do not expect future rounds. 

Country of applicant institution: Any

Department of Health and Social Care (including NIHR)

The NIHR and UK Research and Innovation (UKRI) have launched a new call for research proposals on the risk factors, transmission and prevalence of the COVID-19 virus SARS-CoV-2These two highlight notices form part of a rolling call for research proposals on COVID-19, run by NIHR and UKRI.

  • Highlight notice one - COVID-19 virus (SARS-CoV-2) research on transmission

    Research applications are invited to investigate the routes of transmission in different environments and groups.
  • Highlight notice two - COVID-19 virus (SAR CoV-2) research on priority groups: transmission, risk factors and seroprevalence

    This highlight notice identifies a policy need for further research with children, health and social care workers, and residents in nursing and residential care homes.

The size of grants varies according to the needs of each research project. Funding covers short-term studies for up to one year.

Closing date: 1st June 2020
Applications due by 9am

Country of applicant institution: See website for details of who can apply. 

International Society for Infectious Diseases

ISID’s research grants are one of the Society’s signature programs and are instrumental in fulfilling ISID’s commitment to funding researchers from countries which bear the greatest burden of infectious disease. To date over 175 grants have been awarded to infectious diseases researchers from 46 countries. Due to a high volume of applications, ISID is now prioritizing low and lower-middle income countries.

Areas of interest include, but are not limited to:

  • Investigations of the epidemiology, pathophysiology, diagnosis of infectious disease
  • The epidemiology and control of healthcare-acquired infections
  • Modelling of cost-effective interventions
  • The implementation of Infection control measures in low and lower-middle-income countries
  • Antimicrobial resistance (AMR)

ISID’s research grant applications are open to researchers who live and work in low or lower-middle income countries as classified by the World Bank, who are less than forty years of age, and who have not previously had the opportunity to work or study outside of their region, or received major research funding including ISID grants.

Closing date: 21st June 2020
Country of applicant institution: See website for list of countries